China Kicks Off Pharma Anti-Trust Push With Fine For DSM Partner Simcere

Crackdown Not Limited To Big Tech

While Alibaba and big tech giants are facing antitrust litigations in China, one pharma company finds itself land in hot water with a hefty fine.

Antitrust  law gavel
CHINA IMPOSES CNY100M FINE TO SIMCERE FOR ANTITRUST VIOLATIONS • Source: Shutterstock

More from China

More from Focus On Asia